A potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study.

Janwillem W H Kocks Marjan KerkhofJan ScherpenisseAimée van de MaatIris van Geer-PostmusThomas le RütteJan SchaartReinold O B GansHuib A M Kerstjens

Published in: ERJ open research (2022)

This study suggests caution when prescribing systemic corticosteroids to patients with #COVID19 who show mild-to-moderate pulmonary symptoms because a harmful effect cannot be excluded https://bit.ly/3P4nOjQ.

Keyphrases

coronavirus disease
sars cov
primary care
pulmonary hypertension
low dose
early onset
high dose
emergency department
sleep quality
drug induced
risk assessment
electronic health record